Novo Nordisk flags patient data breach from some clinical trials in cyberattack

Novo Nordisk reported an IT security incident involving unauthorized access to internal systems.


Certain non public, including personal, data was copied externally, prompting notifications to affected parties.


Some IT systems were taken offline in response, while the company stated that business operations were unaffected.

Novo Nordisk, traded as CPSE:NOVO B, is addressing this cybersecurity incident against a backdrop of recent share price pressure. The stock closed at DKK281.2, with the price down 5.2% over the past 30 days and down 14.9% year to date. Over the past year, the share price has declined 43.3%, while the 5 year return stands at 21.4%.

https://finance.yahoo.com/sectors/healthcare/articles/novo-nordisk-cybersecurity-breach-puts-171108556.html